CAS 1807900-80-6

Fulvestrant S Enantiomer

CAS: 1807900-80-6

Formel: C₃₂H₄₇F₅O₃S

Molekulargewicht: 606.78

Ref: 4Z-F-3138

(7α,17β)-7-[9-[(R)-(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol

Kontrolliertes Produkt

CAS: 1807900-80-6

Estradiol is a steroid hormone that belongs to the estrogens group. It is used for the treatment of breast cancer, metastatic breast cancer and estrogen receptor-positive breast cancer. Estradiol has been shown to inhibit the growth of human breast cancer cells in vitro and in vivo. It binds to estrogen receptors, which leads to a decrease in the production of other hormones. This drug also has anti-estrogenic effects on breast tissue, which may be due to its ability to bind with estrogen receptors and act as an antagonist.

Formel: C₃₂H₄₇F₅O₃S

Reinheit: Min. 95%

Molekulargewicht: 606.8 g/mol

Ref: 3D-HXC90080

Fulvestrant R Enantiomer

CAS: 1807900-80-6

Formel: C₃₂H₄₇F₅O₃S

Molekulargewicht: 606.78

Ref: ST-EA-CP-F24037

Fulvestrant (R enantiomer)

CAS: 1807900-80-6

Fulvestrant R enantiomer is the less active R enantiomer of Fulvestrant. Fulvestrant is a potent estrogen receptor antagonist with an IC50 of 9.4 nM.

Formel: C₃₂H₄₇F₅O₃S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 606.77

Ref: TM-T11334